Liquid Biopsy Market by Manufacturers, Countries, Type and Application, Forecast to 2022

According to Stratistics MRC, the Global Liquid Biopsy market is expected to grow from $310.0 million in 2016 to reach $1201.52 million by 2023 with a CAGR of 21.3%. Increasing research & developments and clinical trials for diagnostics, and technological developments are some of the factors driving the market growth. Moreover, growing prevalence of cancer, increasing awareness about liquid biopsy are the factors fostering the market growth. On the other hand, higher costs and complex regulations are restraining the market growth.
Liquid biopsy tests are used to help find cancer at an early stage. These tests are performed to interpret the molecular aspects of cancer across the healthcare and research settings, such as research laboratories, physicians, pathological and hospitals. The circulating tumor cells leads the market globally with the largest market share and is expected to grow with a highest CAGR during the forecast period. By cancer type, lung cancer segment is expected to witness high growth rate during the forecast period. North America emerged as the major revenue generating region in the global market due to innovative technological developments, and increasing incidence of cancer rates in the Canada and U.S. 

Some of the key players in global liquid biopsy market include Roche Diagnostics, Guardant Health, Inc, Illumina, Inc, Biocept, Inc, Myriad Genetics, Inc, Qiagen N.V. , Genomic Health, Inc 
Thermo Fisher Scientific Inc , Bio-Rad Laboratories, Inc, Epic Sciences, Exosome, Cynvenio 
Guardant Health, Personal Genome Diagnostics and Janssen Diagnostics, LLC. 

Clinical Applications Covered:
• Treatment Monitoring 
• Recurrence Monitoring
• Early Cancer Screening 
• Therapy Selection

Product and Services Covered:
• Platforms & Instruments
• Assay Kits & Reagents
• Services
Cancer Types Covered:
• Breast Cancer
• Liver Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Other Cancer Types

Circulating Biomarkers Covered:
• Circulating Tumor DNA (CTDNA) 
• Extracellular Vesicles (Evs) 
• Circulating Tumor Cells 
• Cell-Free DNA 
• Exosomes
• Other Circulating Biomarkers
About Market Reports Center;
Market Reports Center is an e-commerce platform obliging the needs of knowledge workers, experts, professionals who are subject to market research information for their work, or to make strategic business decisions. We are dedicated to create a comprehensive offering of market research which is accurate, credible and affordable.

Connect for more details:
Sam Collins
Market Reports Center
1-646-883-3044 (US)


Comments

Popular posts from this blog

United States Nasal Cannulas Market: Analysis, Competitive Landscape and Market Forecasts to 2018- 2025

United States Hemoglobin Analyzers Market Analysis, Market Size, Regional Outlook, Competitive Strategies and Forecasts, 2025

Noise-Cancelling Headphones Market- Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2018- 2023